Corcept Therapeutics, Inc. (CORT) Reports Q3 EPS Loss of $0.08
Tweet Send to a FriendGet Alerts CORT Hot Sheet
Price: $1.88 --0%
EPS Growth %: +23.1%
Financial Fact:
Net loss and comprehensive loss: -12.08M
Today's EPS Names:
DSX, REDF, REX, More
EPS Growth %: +23.1%
Financial Fact:
Net loss and comprehensive loss: -12.08M
Today's EPS Names:
DSX, REDF, REX, More
Trade CORT Now!
Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q3 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10).
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- Best Buy (BBY) Posts Q1 adj.-EPS of 32c; Comps Down 1.1%
- Monro Muffler, Inc. (MNRO) Reports In-Line Q4 EPS; Guides Q1, FY14
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
